Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 24Terminated 19Active not recruiting 16Withdrawn 8Unknown 2No longer available 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1

Interventions

Cisplatin 512Radiotherapy 376Cyclophosphamide 361Carboplatin 354Capecitabine 341Oxaliplatin 331Paclitaxel 328Gemcitabine 318Docetaxel 314Fluorouracil 288Drug Therapy 271apatinib 245Bevacizumab 243camrelizumab 217Etoposide 200Irinotecan 182Doxorubicin 180Leucovorin 160Dexamethasone 160pembrolizumab 150sintilimab 143Neoadjuvant Therapy 142anlotinib 139Pemetrexed 138Cytarabine 138Blood Specimen Collection 138Surgical Procedures, Operative 130toripalimab 128Radiosurgery 127S 1 (combination) 124

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × copanlisib × Clear all
NCT05387616 2024-03-12

Alternative-C

Ludwig-Maximilians - University of Munich

Phase 2 Unknown
98 enrolled
Lymphoid

Lymphoma, Follicular

NCT04263584 2024-01-05

COPA-R-CHOP

University Hospital Muenster

Phase 2 Unknown
62 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡